The effect of a clinically effective and non-effective dose of lorazepam on 7.5% CO2-induced anxiety

Diaper, Alison; Papadopoulos, Andreas; Rich, Ann S.; Dawson, Gerry R.; Dourish, Colin T.; Nutt, David J.; Bailey, Jayne E.

Abstract

Symptoms of anxiety induced by 7.5% CO2 inhalation can be attenuated by acute administration of GABAA receptor anxiolytics such as lorazepam and alprazolam. This study investigated if these effects are dose-related, by comparing a 0.5 mg dose (considered non-clinically effective) and a 2 mg dose of lorazepam (clinically effective) on 7.5% CO2 inhalation. Eighteen healthy males (mean age 20.6 years, SD 1.29), judged physically and mentally fit, attended three visits, each one week apart, to take each treatment in a randomised double-blind crossover design. Drugs were given 60 min prior to 20 min air inhalation, followed by 20 min 7.5% CO2 inhalation. The order of gas presentation was single blind. Subjective ratings using visual analogue scales (VAS) and questionnaires were recorded before and after each inhalation. Blood pressure (BP), heart rate (HR), respiration rate (RR) and expired CO2 were recorded during each inhalation. Inhalation of 7.5% CO2 significantly raised BP, HR, RR and expired CO 2. Ratings of feeling like leaving the room were significantly lower on 2 mg compared with 0.5 mg and placebo, and dose-dependent trends were seen in scores for VAS fearful, anxious, stressed, tense, and worried. Results may be indicative of dose-dependent effects of lorazepam in a CO2 model of anxiety. Copyright © 2012 John Wiley & Sons, Ltd. Copyright © 2012 John Wiley & Sons, Ltd.

Citation

Diaper, A., Papadopoulos, A., Rich, A. S., Dawson, G. R., Dourish, C. T., Nutt, D. J., & Bailey, J. E. (2012). The effect of a clinically effective and non-effective dose of lorazepam on 7.5% CO2-induced anxiety. Human Psychopharmacology: Clinical and Experimental, 27(6), 540-548. https://doi.org/10.1002/hup.2261

• Journal Article Type: Article
• Online Publication Date: Oct 2, 2012
• Publication Date: Nov 1, 2012
• Deposit Date: Nov 21, 2019
• Journal: Human Psychopharmacology
• Print ISSN: 0885-6222
• Electronic ISSN: 1099-1077
• Publisher: Wiley
• Peer Reviewed: Peer Reviewed
• Volume: 27
• Issue: 6
• Pages: 540-548
• DOI: https://doi.org/10.1002/hup.2261
• Public URL: https://uwe-repository.worktribe.com/output/4670117
• Publisher URL: https://doi.org/10.1002/hup.2261